Status:
COMPLETED
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
Lead Sponsor:
Istanbul University
Conditions:
Acute Coronary Syndromes
Acute Myocardial Infarction
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
The investigators hypothesized that complementary intracoronary streptokinase administration to primary percutaneous intervention in patients with acute myocardial infarction may provide limitation in...
Eligibility Criteria
Inclusion
- Continuous chest pain that lasted \> 30 minutes within the preceding 12 hours
- ST-segment elevation of at least 1 mm in 2 contiguous leads on the ECG
- Infarct related artery (IRA) occlusion (TIMI grade 0) at the angiography
Exclusion
- Contraindications to streptokinase, tirofiban, aspirin, clopidogrel, or heparin
- Culprit lesion in saphenous vein graft
- TIMI grade II-III flow in IRA
- Additional epicardial stenosis in the IRA distal to stented segment (significant or insignificant)
- Presence of left bundle branch block
- History of prior MI
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00627809
Start Date
January 1 2007
End Date
February 1 2008
Last Update
June 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
Istanbul, Turkey (Türkiye), 34290